1,549
Participants
Start Date
February 3, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
January 31, 2024
EarlyTect® Bladder Cancer test
A highly accurate and sensitive real-time PCR employing Linear Target Enrichment and Quantitative Methylation-Specific PCR (LTE-qMSP) for measuring PENK methylation in urine DNA to detect bladder cancer in hematuria patients.
RECRUITING
Asan Medical Center, Seoul
Lead Sponsor
Seoul National University Hospital
OTHER
Korea University Anam Hospital
OTHER
National Cancer Center, Korea
OTHER_GOV
Pusan National University Hospital
OTHER
Samsung Medical Center
OTHER
Ajou University School of Medicine
OTHER
Ulsan University Hospital
OTHER
Chonnam National University Hospital
OTHER
Seoul Clinical Laboratories
UNKNOWN
Seoul National University Bundang Hospital
OTHER
Asan Medical Center
OTHER